Evidence map›Paper›PMID 28396474›Full record

ArticlePhilosophical transactions of the Royal Society of London. Series B, Biological sciences2017

Evaluating the frequency of asymptomatic Ebola virus infection.

Placide Mbala, Marc Baguelin, Ipos Ngay, Alicia Rosello, Prime Mulembakani, Nikolaos Demiris, W John Edmunds, Jean-Jacques Muyembe

Abstract read
In one paragraph

Article in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
  10. Review
  11. Article
  12. The 2013-2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Placide MbalaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Marc BaguelinModelling and Economics Department, Public Health England, London NW9 5EQ, UK marc.baguelin@phe.gov.uk.ORCID http://orcid.org/0000-0003-3867-1953
Ipos NgayInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.
Alicia RoselloModelling and Economics Department, Public Health England, London NW9 5EQ, UK.
Prime MulembakaniMETABIOTA, Kinshasa, Democratic Republic of Congo.
Nikolaos DemirisDepartment of Statistics, Athens University of Economics and Business, Athens 10434, Greece.
W John EdmundsDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
Jean-Jacques MuyembeInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The potential for asymptomatic infection from Ebola viruses has long been questioned. Knowing the proportion of infections that are asymptomatic substantially changes the predictions made by mathematical models and alters the corresponding decisions based upon these models. To assess the degree of asymptomatic infection occurring during an Ebola virus disease (EVD) outbreak, we carried out a serological survey in the Djera district of the Equateur province of the Democratic Republic of the Congo affected by an Ebola outbreak in 2014. We sampled all asymptomatic residents (

Indexed as

AdolescentAdultAntibodies, ViralAsymptomatic InfectionsDemocratic Republic of the CongoEbolavirusFemaleHemorrhagic Fever, EbolaHumansImmunoglobulin GImmunoglobulin MMaleModels, TheoreticalPrevalenceSeroepidemiologic StudiesYoung AdultAntibodies, ViralImmunoglobulin GImmunoglobulin Masymptomatic infectionEbola virus diseasehousehold surveyserology

Identifiers

PMID28396474
PMCPMC5394641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.